Clinical Research Directory
Browse clinical research sites, groups, and studies.
Comparison of Intralipid With SMOF Lipid Following HSCT
Sponsor: Shahid Beheshti University
Summary
The goal of this clinical trial is to have a successful engraftment in after bone transplantation. Acute leukemia patient of both sexes aged 2 to 18 years, who are transplant candidates, participate in this study. Primary hypothesis is Patients receiving SMOF LIPID will have better grafts than patients receiving intralipid. Also, complications after surgery and malnutrition will be less in this group.
Official title: Comparison of the Effect of Intralipid Parenteral Nutritional With SMOF Lipid Parenteral Nutritional on Biochemical Markers, Hematologic Markers, and Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Key Details
Gender
All
Age Range
2 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2024-10-12
Completion Date
2025-12
Last Updated
2024-10-16
Healthy Volunteers
No
Interventions
SMOF lipid
The SMOF lipid is given to the patient as a fat component of total parenteral nutrition.
INTRALIPIDS
The Intralipid will be given to the patient as fat component of total parenteral nutrition.
Locations (1)
Children's Medical Center, Pediatrics Center of Excellence, Tehran University of Medical Sciences, Tehran, Iran
Tehran, Iran